Heart failure: Pathophysiology and clinical picture

Contributions to Nephrology

Volumn 164, Issue , 2010, Pages 1-10

  Palazzuoli, Alberto ^a   Nuti, Ranuccio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEART; HEART FAILURE; HEART MUSCLE; HOMEOSTASIS; HUMAN; METABOLIC DISORDER; METABOLISM; NEUROSECRETION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

HEART; HEART FAILURE; HOMEOSTASIS; HUMANS; MYOCARDIUM; NEUROSECRETORY SYSTEMS; WATER-ELECTROLYTE IMBALANCE;

EID: 77955479938     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000313714     Document Type: Article

References (29)

1. Krumholz HM, Parent EM, Tu N, et al: Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104.
2. McAlister FA, Lawson FM, Teo KK, et al: A systemic review of randomized trials of disease management programs in heart failure. Am J Med 2001;110:378-384.
3. Felker GM, Adams KF, Konstam MA, O'Connor CM, Gheorghiade M: The problem of decompensated heart failure: nomenclature classification and risk classification. Am Heart J 2003:145: 518-523.
4. Packer M: Evolution of the neurohormonal hypothesis to explain the progression of chronic heart failure. Eur Heart J 1995;16(suppl F):4-6.
5. Gheorghiade M, De Luca L, Bonow RO: Neurohormonal inhibition in heart failure: insights from recent clinical trials. Am J Cardiol 2005;96:3L-9L.
6. Francis GS: Pathophysiology of chronic heart failure. Am J Med 2001;110:37-46.
7. Francis GS, McDonald KM: Left ventricular hypertrophy: an initial response to myocardial injury. Am J Cardiol 1992;69:3G-9G.
8. Tagawa H, Koide M, Sata H, et al: Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading. Circ Res 1998;82:751-761.
9. Anversa P, Olivetti G, Leri A, et al: Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens 1997;6:169-176.
10. Spinale FG, Coker ML, Thomas CV, et al: Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure. Circ Res 1998;82:482-495.
11. Mulieri RA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR: Altered myocardial force frequency relation in human heart failure. Circulation 1992;85:1743-1750.
12. Beohar N, Erdogan AK, Lee DC, et al: Acute heart failure syndrome and coronary perfusion. J Am Coll Cardiol 2008;52:13-16.
13. Chatterjee K: Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol 2005;95:8B-13B
14. Lavoie JL, Sigmund CD: Minireview: overview of the renin-angiotensin system - an endocrine and paracrine system. Endocrinology 2003;144:2179-2183.
15. Mehta PK, Griendling K: Angiotensin II cell signaling: physiological and pathological effects in cardiovascular system. Am J Physiol Cell Physiol 2007;292:82-97.
16. Packer M: The neurohormonal hypothesis: a theory to explain heart disease progression in heart failure. J Am Coll Cardiol 1992;20:248-254.
17. Pepper GS, Lee RW: Sympathetic activation in heart failure and its treatment with betablockade. Arch Intern Med 1999;159:225-234.
18. Floras JS: Sympathetic nervous system activation in human heart failure clinical implications of an updated model. J Am Coll Cardiol 2009;54:375-385.
19. Floras JS: Alterations in the sympathetic and parasympathetic nervous system in heart failure; in Mann D (ed): A Companion to Braunwald's Heart Disease. Philadelphia, Harcourt, 2004, pp 247-277.
20. Goldsmith SR: The role of vasopressin in congestive heart failure. Cleve Clin J Med 2006;3: S19-S23.
21. Chen HH, Schrier RW: Pathophysiology of volume overload in acute heart failure syndromes. Am J Med 2006;119: S11-S16.
22. Metra M, Dei Cas L, Bristow MR: The pathophysiology of acute heart failure - it is a lot about fluid accumulation. Am Heart J 2008;155:1-5.
23. Milo O, Cotter G, Kaluski E, et al: Inflammatory and neurohormonal activation in cardiogenic pulmonary edema: implications on the pathogenesis and outcome of acute ischemic versus non-ischemic acute heart failure. Am J Cardiol 2003;92:222-226.
24. Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M: Fluid overload in acute heart failure - re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 2008;10:165-169.
25. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al: 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119: e391-e479.
26. Gheorghiade M, Zannad, Sopko FG, Klein L, Piña IL, Konstam MA, et al: Acute heart failure syndromes: current state and framework for future research. Circulation 2005;112:3958-3968.
27. Stevenson LW, Massie BM, Francis GS: Optimizing therapy for complex or refractory heart failure: a management algorithm. Am Heart J 1998;135(suppl):S293-S309.
28. Felker GM, Adams KF, Konstam MA, O'Connor CM, Gheorghiade M: The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 2003;145: S18-S25.
29. Gheorghiade M, Pang P: Acute heart failure syndromes. J Am Coll Cardiol 2009;53:557-573.